Bayzed does healthcare

BRIEF: Hengrui executive to sell nearly 500,000 A-shares

Pharmaceutical company Jiangsu Hengrui Pharmaceuticals Co. Ltd. (1276.HK; 600276.SH) said on Sunday that executive director and senior vice president Sun Jieping will sell up to 476,700 of his A-shares in…

BRIEF: Dobot partners with YSB on pharmacy-focused robots

Robot manufacturer Shenzhen Dobot Corp. Ltd. (2432.HK) on Tuesday announced a strategic collaboration with YSB Inc. (9885.HK) to jointly develop robots for pharmaceutical applications. The partnership will see Dobot spearhead…
Illustration of a drug lab

A Drug Company’s Forced Sales, and a Family Feud in Shanghai

A family of biotech contracting companies in Wuxi has begun selling offshore assets under pressure from Western governments worried about national security. And a family feud in Shanghai has left a $1 billion luxury villa complex in limbo.
Hengrui Pharma

Hengrui Pharma accelerates bid for global brand status

The Chinese drugmaker has outlined plans for a secondary listing in Hong Kong to raise its international profile and bolster its overseas ambitions Key Takeaways: Hengrui Pharmaceuticals started out producing…